Filing metadata

Accession number
0001209191-22-019311
Form type
Form 4
Filer
IRulya Therapeutics Inc.
CIK
CIK 1662774
Filed
Mar 16, 2022
Reporting period
Mar 14, 2022
Description
Insider transaction

Explore SEC Filings Hub